TAF9 and metabolic dysfunction-associated steatotic liver disease: We found that TAF9 overexpression significantly decreased the protein expression of LD accumulation-related genes (ACSL1 and ADRP) and attenuated the accumulation of LDs in HFD-induced NAFLD, as indicated by Oil Red O staining.